Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(20 sites)

Austria

University Hospital Graz, Graz

Medizinische Universität Innsbruck, Innsbruck

Kepler University Hospital, Linz

University Hospital St. Pölten, Sankt Pölten

Denmark

Aarhus University Hospital, Aarhus

Norway

Haukeland University Hospital, Bergen

Sorlandet Sykehus, Kristiansand

Oslo University Hospital, Oslo

Stavanger University Hospital, Stavanger

St Olavs Hospital, Trondheim

Sweden

Gävle Hospital, Gävle

Sahlgrenska University Hospital, Gothenburg

Ryhov County Hospital, Jönköping

Kalmar Country Hospital, Kalmar

Skåne University Hospital, Lund

Örebro University Hospital, Örebro

Karolinska Institutet, Stockholm

Sundsvall Hospital, Sundsvall

Norrlands Universitetssjukhus, Umea, Sweden, Umeå

Uppsala University Hospital, Uppsala